logo
Paraneoplastic hypertrophic osteopathy in 30 dogs
Canine osteosarcoma cell lines from patients with differing serum alkaline phosphatase concentrations display no behavioural differences in vitro
Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document
Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma
Identification of novel tumour-associated antigens in canine mammary gland tumour
Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma
The use of COLD-PCR, DHPLC and GeneScanning for the highly sensitive detection of c-KIT somatic mutations in canine mast cell tumours
Adjuvant therapy with carboplatin and pamidronate for canine appendicular osteosarcoma*
Analysis of genomic mutation and immunohistochemistry of platelet-derived growth factor receptors in canine vascular tumours
Novel acyclic nucleotide analogues GS-343074 and GS-424044 demonstrate antiproliferative and pro-apoptotic activity in canine neoplastic cell lines
Serial haemostatic monitoring of dogs with multicentric lymphoma
Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999–2012)*
Flow-cytometric detection of phenotypic aberrancies in canine small clear cell lymphoma
Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma
Determination of platinum surface contamination in veterinary and human oncology centres using inductively coupled plasma mass spectrometry
Masitinib mesylate for metastatic and non-resectable canine cutaneous mast cell tumours
Characterization of HOX gene expression in canine mammary tumour cell lines from spontaneous tumours